For decades, radiation has been a cornerstone of thyroid cancer care. But it may soon be phased out entirely for many thyroid tumors as emerging research casts doubt on whether it benefits patients.
A study published Wednesday in the New England Journal of Medicine suggests that surgery alone might be sufficient to cure the lowest-risk thyroid cancers, and that follow-up treatment with radioactive iodine offers no additional benefit for these patients.